Last update 01 Nov 2024

TOP1 x GD2

Basic Info

Related Targets
TOP1GD2

Related

1
Drugs associated with TOP1 x GD2
M-3554
Target
GD2 x TOP1
Mechanism
GD2 inhibitors [+1]
Active Org.
Merck Pharmaceutical Manufacturing (Jiangsu) Co., Ltd.Merck Pharmaceutical Manufacturing (Jiangsu) Co., Ltd.Startup [+1]
Originator Org.
Merck KGaA
Active Indication
Advanced Malignant Solid Neoplasm [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with TOP1 x GD2
NCT06641908 / Not yet recruitingPhase 1
A Phase 1, Two-Part, Multicenter, Open-Label First in Human Study of Anti-GD2 Antibody Drug Conjugate M3554 in Participants With Advanced Solid Tumors
100 Clinical Results associated with TOP1 x GD2
Login to view more data
100 Translational Medicine associated with TOP1 x GD2
Login to view more data
0 Patents (Medical) associated with TOP1 x GD2
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free